QT IMAGING HOLDINGS, INC. (QTI) Current Ratio
- Current ratio · latest quarter: Value 3.10×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.10× | Current assets / current liabilities. $29.42M ÷ $9.50M ≈ 3.10× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 29.42M USD | Assets, Current |
| Current obligations | 9.50M USD | Liabilities, Current |
| Cash and equivalents | 10.92M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 7.40M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 9.87M USD | Inventory, Net |
| Payables | 3.01M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $29.42M | $9.50M | $10.92M | (m) | $7.40M | $9.87M | $3.01M | (m) | 3.10× |
| 2026-03-31 | $21.20M | $8.53M | $6.90M | (m) | $6.35M | $6.83M | $2.93M | (m) | 2.49× |
| 2025-12-31 | $22.09M | $7.87M | $10.41M | (m) | $5.78M | $5.03M | $3.58M | (m) | 2.81× |
| 2025-09-30 | $11.29M | $12.74M | (m) | (m) | $3.24M | $5.24M | $2.02M | (m) | 0.89× |
| 2025-06-30 | $10.67M | $6.31M | (m) | (m) | $3.65M | $3.23M | $1.60M | (m) | 1.69× |
| 2025-03-31 | $9.81M | $5.28M | (m) | (m) | $2.78M | $2.87M | $869.58K | (m) | 1.86× |
| 2024-12-31 | $4.92M | $9.79M | $1.17M | (m) | $67.00K | $3.14M | $803.00K | (m) | 0.50× |
| 2024-09-30 | $5.78M | $5.43M | (m) | (m) | $256.89K | $3.18M | $768.26K | (m) | 1.06× |
| 2024-06-30 | $9.49M | $15.27M | (m) | (m) | $669.14K | $3.35M | $549.58K | (m) | 0.62× |
| 2024-03-31 | $11.43M | $4.37M | (m) | (m) | $482.36K | $4.12M | $711.77K | (m) | 2.62× |
| 2023-12-31 | $4.82M | $7.34M | (m) | (m) | $1.29K | $4.42M | $1.36M | (m) | 0.66× |
| 2023-09-30 | $129.89K | $8.93M | (m) | (m) | (m) | (m) | $622.32K | (m) | 0.01× |
| 2023-06-30 | $54.23K | $8.02M | (m) | (m) | (m) | (m) | $453.89K | (m) | 0.01× |
| 2023-03-31 | $467.65K | $6.40M | (m) | (m) | (m) | (m) | $357.71K | (m) | 0.07× |
| 2022-12-31 | $250.70K | $4.19M | (m) | (m) | (m) | (m) | $195.06K | (m) | 0.06× |
| 2022-09-30 | $844.98K | $2.65M | (m) | (m) | (m) | (m) | $230.68K | (m) | 0.32× |
| 2022-06-30 | $585.37K | $1.57M | (m) | (m) | (m) | (m) | $278.28K | (m) | 0.37× |
| 2022-03-31 | $907.72K | $832.33K | (m) | (m) | (m) | (m) | $208.23K | (m) | 1.09× |
| 2021-12-31 | $1.16M | $633.64K | (m) | (m) | (m) | (m) | $28.10K | (m) | 1.83× |
| 2021-09-30 | $2.78M | $1.53M | (m) | (m) | (m) | (m) | $1.23M | (m) | 1.82× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |